Ørjan L. Apeland

Anders has been acting COO at Curida since fall 2023 and became CEO in May 2024. He brings extensive experience from the pharma, pharmacy and pharma services industry from his role as CEO in Norway for Boots pharmacy and Alliance Healthcare pharma wholesale (Cencora). Furthermore, Anders has over a decade of experience in development and end-to-end operations in FMCG, food and beverage from multiple executive roles in Orkla and Carlsberg, located in Scandinavia and in Asia. Anders holds an MSc in Chemical Engineering from Chalmers University Gothenburg and Imperial College London, as well as a BSc in finance from Gothenburg University.

Álvaro López joined Curida as Business Development Director in January 2025. In this role, Álvaro will be fully responsible for overseeing Commercial Operations, including Sales, Marketing, and Business Intelligence. With over 20 years of experience in Business Development and Sales within the Healthcare and Pharmaceutical industries, Álvaro brings a wealth of expertise in sterile liquid technologies, particularly in BFS technologies and Nasal Sprays. He has previously held several senior commercial positions, including Sales & Marketing Director and Business Development Director, within the CDMO sector. Álvaro holds a degree in Law, a Postgraduate degree in International Business, and an Executive MBA from IE Business School. 

Terje Gabrielsen has been Chief Financial Officer of Curida since September 2017. Prior to his appointment in Curida, he worked as CFO Thales Norway, Denofa, Nammo Group, Raufoss Group, Unitor North America and Alcatel Telettra. Mr Gabrielsen holds an MSc in Business Administration from BI Norwegian Business School.

Jens Schanche Dølør possesses a comprehensive background in military education and experience, having held various leadership and human resources roles across different levels within the armed forces. Additionally, he has garnered HR expertise from the healthcare sector. Since March 2024, Jens has served as the Head of Human Resources at Curida Group. In this capacity, he and his HR team deliver a full spectrum of HR support to all organizational levels.

Joe joined Curida in November 2024. Having worked within the pharma industry since 1999, Joe has gained significant international experience leading operations with complex product portfolios for both big pharma and CDMO. Joe has a proven background in building sustainable operational capability and operational excellence within small molecule API’s, finished goods and medical devices.

Joe holds an MSc in Manufacturing from the OU, and a BSc in Engineering Systems from Napier university, Edinburgh.

Peter Sjølie holds a M.Sc. in Production Technology from NTNU Trondheim. Since graduating Peter has worked in the Norwegian research organization SINTEF and space and defence group NAMMO. Starting as a project manager responsible for tech transfers (TT) in Curida in 2019 Peter has obtained extensive experience in the pharmaceutical industry. Especially through leading Curida’s single largest TT-project transferring 15 products (200+ SKU’s) over the course of two years. Since Q4 2021 Peter has been responsible for all tech transfer and development projects in Curida Small Molecules.

Mira has an M.Sc in Molecular Bioscience and Immunology and joined Curida in 2018. She spent her first 3 years as Key Account Manager before moving on to the role of Site Manager at our Diagnostics production site. When the company was acquired by Curida AS in 2022, Curida Diatec reorganized and Mira was asked to temporary lead operations at the two manufacturing sites in addition to business development. In May 2024 Mira was promoted to Director of Curida Biologics. Mira has a background from Basal Medical Research at Oslo University Hospital and a broad experience in sales and customer service from other industries.